Henry N. Young

3.8k total citations
141 papers, 2.6k citations indexed

About

Henry N. Young is a scholar working on General Health Professions, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Henry N. Young has authored 141 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in General Health Professions, 24 papers in Epidemiology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Henry N. Young's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Medication Adherence and Compliance (17 papers) and Opioid Use Disorder Treatment (12 papers). Henry N. Young is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Medication Adherence and Compliance (17 papers) and Opioid Use Disorder Treatment (12 papers). Henry N. Young collaborates with scholars based in United States, Mexico and Egypt. Henry N. Young's co-authors include Elizabeth Cox, Megan A. Moreno, Katie G. Egan, Lauren A. Jelenchick, Tara Becker, Rebecca J. Cline, Alexander S. Yevzlin, Micah R. Chan, María E. Len‐Ríos and Robert J. Sanchez and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Henry N. Young

131 papers receiving 2.4k citations

Peers

Henry N. Young
Kenzie A. Cameron United States
Young Ik Cho United States
Liset van Dijk Netherlands
Kitty S. Chan United States
Kristie L. Foley United States
Sabrina Pit Australia
Lynne S. Nemeth United States
Jennifer K. Carroll United States
Lynne Emmerton Australia
Anton J. Kuzel United States
Kenzie A. Cameron United States
Henry N. Young
Citations per year, relative to Henry N. Young Henry N. Young (= 1×) peers Kenzie A. Cameron

Countries citing papers authored by Henry N. Young

Since Specialization
Citations

This map shows the geographic impact of Henry N. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry N. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry N. Young more than expected).

Fields of papers citing papers by Henry N. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry N. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry N. Young. The network helps show where Henry N. Young may publish in the future.

Co-authorship network of co-authors of Henry N. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Henry N. Young. A scholar is included among the top collaborators of Henry N. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry N. Young. Henry N. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unni, Elizabeth, Lourdes G. Planas, Adriane N. Irwin, et al.. (2025). Gender equity perceptions among pharmacy practice faculty in pharmacy academia. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(4). 271–280.
2.
Crawford, Natalie D., et al.. (2025). Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales. Harm Reduction Journal. 22(1). 139–139.
3.
Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2025). Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care Settings. Journal of the American Medical Directors Association. 26(4). 105522–105522.
4.
5.
6.
Young, Henry N., et al.. (2024). Innovation, Affordability, Access: Alzheimer Disease Drugs and the Inflation Reduction Act. The American Journal of Managed Care. 30(6). e169–e171. 4 indexed citations
7.
Crawford, Natalie D., et al.. (2024). Feasibility of reaching populations at high risk for HIV in community pharmacies. Journal of the American Pharmacists Association. 64(6). 102239–102239.
8.
Welsh, Justine W., Amanda J. Abraham, Natalie D. Crawford, et al.. (2024). Community pharmacy-based buprenorphine programs and pharmacists' roles, knowledge, attitudes, and barriers to providing buprenorphine-related services: A systematic review. Journal of the American Pharmacists Association. 65(2). 102319–102319. 2 indexed citations
9.
10.
Soyres, François de, Ana María Santacreu, & Henry N. Young. (2023). Demand-Supply Imbalance during the COVID-19 Pandemic: The Role of Fiscal Policy. 105(1). 6 indexed citations
11.
Punches, Brittany E., Jason J. Bischof, Simiao Li‐Sauerwine, et al.. (2023). Patient perceptions of microaggressions and discrimination toward patients during emergency department care. Academic Emergency Medicine. 30(12). 1192–1200. 2 indexed citations
12.
Soyres, François de, et al.. (2023). What is Measured in National Accounts?. International Finance Discussion Paper. 2023.0(1375). 1–23.
13.
Welsh, Justine W., et al.. (2022). Demographic and socioeconomic correlates to buprenorphine access in pharmacies. Journal of the American Pharmacists Association. 63(3). 751–759. 6 indexed citations
14.
Thomas, Tyan, Radhika Devraj, Lourdes G. Planas, et al.. (2022). Gender equity perceptions among social and administrative science faculty: A qualitative evaluation. Journal of the American Pharmacists Association. 63(1). 50–57.e2. 4 indexed citations
15.
Chen, Ronald C., Henry N. Young, Anant Mandawat, et al.. (2021). Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate Cancer and Prostatic Diseases. 24(4). 1093–1102. 2 indexed citations
16.
Perri, Matthew, et al.. (2021). Impact of drug utilization management policy on prescription opioid use in Georgia Medicaid. Journal of Pharmaceutical Health Services Research. 12(2). 188–193. 1 indexed citations
17.
Plantinga, Laura, Camille P. Vaughan, Alayne D. Markland, et al.. (2020). Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom. Clinical Therapeutics. 42(12). e259–e274. 4 indexed citations
18.
Young, Henry N., et al.. (2018). Race and Time to Receipt of Androgen Deprivation Therapy Among Men With Metastatic Prostate Cancer. Journal of the National Medical Association. 111(3). 246–255. 5 indexed citations
19.
Jayawardhana, Jayani, Amanda J. Abraham, Henry N. Young, & Matthew Perri. (2018). Opioids in Georgia Medicaid: gender and insurance disparities in utilization and potential inappropriate prescribing practices. Journal of Pharmaceutical Health Services Research. 9(2). 101–108. 6 indexed citations
20.
Young, Henry N. & Rebecca J. Cline. (2003). “Look George, There's Another One!” The Volume and Characteristics of Direct-to-Consumer Advertising in Popular Magazines. Journal of Pharmaceutical Marketing & Management. 15(3). 7–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenzie A. Cameron Breakdown of academic impact, for papers by Young Ik Cho Breakdown of academic impact, for papers by Liset van Dijk Breakdown of academic impact, for papers by Kitty S. Chan Breakdown of academic impact, for papers by Kristie L. Foley Breakdown of academic impact, for papers by Sabrina Pit Breakdown of academic impact, for papers by Lynne S. Nemeth Breakdown of academic impact, for papers by Jennifer K. Carroll Breakdown of academic impact, for papers by Lynne Emmerton Breakdown of academic impact, for papers by Anton J. Kuzel
Rankless by CCL
2026